CYRX(CYRX)
CYRX
Q4 2026 EPS Estimate
$-0.19
Nov 3, 2026 · Reports after close
Revenue Estimate
$49M
Analyst Sentiment
Wall St. Consensus
Buy19 analysts·Moderate coverage
70
Score
15 Buy (79%)4 Hold (21%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1579%
Hold
421%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$13.50
-21.2%
Consensus
$19.00
+10.9%
Bull
$25.00
+45.9%
12-Month Target Range19 analysts
$13.50$19.00$25.00
Current $17.13Consensus
Current Price
$17.13
Upside to Consensus
$1.87
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+9.95%
EPS—
FY2028
Rev+8.89%
EPS—
FY2029
Rev+7.34%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $195M | $215M | $234M | $251M | $274M |
| Low | $194M | $213M | $228M | $249M | $272M |
| High | $197M | $217M | $241M | $253M | $277M |
| EBITDA Avg | $-91M | $-100M | $-109M | $-117M | $-127M |
| Low | $-92M | $-101M | $-112M | $-118M | $-129M |
| High | $-90M | $-99M | $-106M | $-116M | $-126M |
| EBIT Avg | $-105M | $-116M | $-126M | $-135M | $-148M |
| Low | $-106M | $-117M | $-130M | $-137M | $-149M |
| High | $-104M | $-115M | $-123M | $-134M | $-146M |
| Net Income Avg | $-39M | $-32M | $-26M | $-27M | $-22M |
| Low | $-40M | $-33M | $-35M | $-27M | $-22M |
| High | $-39M | $-32M | $-6M | $-26M | $-21M |
| EPS Avg | $-0.79 | $-0.64 | $-0.44 | $-0.53 | $-0.43 |
| Low | $-0.80 | $-0.65 | $-0.70 | $-0.54 | $-0.44 |
| High | $-0.78 | $-0.64 | $-0.13 | $-0.52 | $-0.43 |
| Analysts (Rev / EPS) | 6 / 4 | 6 / 4 | 5 / 4 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $49M | $50M | $52M | $54M | $53M | $55M | $57M | $58M |
| Low | $48M | $50M | $52M | $54M | $53M | $55M | $56M | $58M |
| High | $49M | $50M | $53M | $54M | $54M | $55M | $57M | $58M |
| EBITDA Avg | $-23M | $-23M | $-24M | $-25M | $-25M | $-26M | $-26M | $-27M |
| Low | $-23M | $-23M | $-24M | $-25M | $-25M | $-26M | $-26M | $-27M |
| High | $-22M | $-23M | $-24M | $-25M | $-25M | $-25M | $-26M | $-27M |
| EBIT Avg | $-26M | $-27M | $-28M | $-29M | $-29M | $-30M | $-31M | $-31M |
| Low | $-26M | $-27M | $-28M | $-29M | $-29M | $-30M | $-31M | $-31M |
| High | $-26M | $-27M | $-28M | $-29M | $-29M | $-29M | $-30M | $-31M |
| Net Income Avg | $-9M | $-8M | $-9M | $-9M | $-8M | $-8M | $-3M | $-3M |
| Low | $-9M | $-9M | $-9M | $-9M | $-8M | $-8M | $-3M | $-3M |
| High | $-9M | $-8M | $-9M | $-8M | $-8M | $-8M | $-3M | $-3M |
| EPS Avg | $-0.18 | $-0.17 | $-0.18 | $-0.17 | $-0.16 | $-0.16 | $-0.05 | $-0.06 |
| Low | $-0.18 | $-0.17 | $-0.18 | $-0.17 | $-0.16 | $-0.16 | $-0.06 | $-0.06 |
| High | $-0.18 | $-0.17 | $-0.18 | $-0.17 | $-0.16 | $-0.16 | $-0.05 | $-0.06 |
| Analysts (Rev / EPS) | 5 / 2 | 5 / 2 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |